SK Biopharmaceuticals. (326030.KQ) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
84.73
829.01
1,573.29
2,317.56

Details

Expected EPS
397.26397825199996
Actual EPS
383.64629058
Surprise EPS
-13.62
Surprise Percent
+3.43%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 383.64629058 per share for Q3 2025.

0 Comments

Share your thoughts